Raymond James Financial
ACH

Raymond James Financial’s Accendra Health ACH Stock Holding History

Raymond James Financial’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,137
Closed -$55.8K – 6185
2025
Q2 		$55.8K Buy
+6,137
New +$45.2K ﹤0.01% 5140

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial's ACH Position: Q3 2025 in Review

Raymond James Financial sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 6,137 shares — an estimated $55.8K sold.

Raymond James Financial first reported a position in ACH in Q2 2025 and held it in 1 quarter. The position peaked at $55.8K in Q2 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Raymond James Financial reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 6,137 Accendra Health shares in Q3 2025, an estimated $55.8K.
  • Raymond James Financial first reported a position in Accendra Health in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Accendra Health position peaked at $55.8K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.